JPMorgan Dad Turns Biotech CEO in Disease Quest

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

Feb. 20 (Bloomberg) -- Ilan Ganot, founder of Solid Ventures, talks about his decision to leave his career to create the biotechnology company after his son, Eytani, was diagnosed with Duchenne muscular dystrophy, a fatal genetic disease. Ganot, a former hedge fund specialist at JPMorgan Chase & Co., now aims to tackle the disease with a strategy he calls condition focus, a sole concentration on DMD. (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change